We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.74B
AUM Growth
-$403M
Cap. Flow
-$540M
Cap. Flow %
-14.42%
Top 10 Hldgs %
17.64%
Holding
421
New
67
Increased
59
Reduced
163
Closed
53

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$85.4M
2
NXPI icon
NXP Semiconductors
NXPI
+$53.8M
3
APTV icon
Aptiv
APTV
+$47.1M
4
MON
Monsanto Co
MON
+$42.2M
5
BLK icon
Blackrock
BLK
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 17.7%
3 Consumer Discretionary 16.53%
4 Energy 10.05%
5 Industrials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHS icon
201
Universal Health Services
UHS
$10.4B
$4.49M 0.12%
31,625
+8,475
+37% +$1.06M
SMFG icon
202
Sumitomo Mitsui Financial
SMFG
$170B
$4.49M 0.12%
505,000
WES icon
203
Western Midstream Partners
WES
$19.5B
$4.49M 0.12%
74,780
-20,450
-21% -$1.27M
NFX
204
DELISTED
Newfield Exploration
NFX
$4.37M 0.12%
120,900
-5,600
-4% -$208K
KTWO
205
DELISTED
K2M Group Holdings, Inc
KTWO
$4.32M 0.12%
+179,675
New +$4.29M
ENDP
206
DELISTED
Endo International plc
ENDP
$4.3M 0.12%
54,050
-67,150
-55% -$5.8M
TOL icon
207
Toll Brothers
TOL
$12.4B
$4.25M 0.11%
111,200
JAH
208
DELISTED
JARDEN CORPORATION
JAH
$4.24M 0.11%
81,900
-29,775
-27% -$1.58M
CSL icon
209
Carlisle Companies
CSL
$12.9B
$4.18M 0.11%
41,775
-6,000
-13% -$588K
E icon
210
ENI
E
$81.4B
$4.18M 0.11%
+117,500
New +$4.33M
ALLE icon
211
Allegion
ALLE
$13.1B
$4.14M 0.11%
+68,900
New +$4.22M
LH icon
212
Labcorp
LH
$26.3B
$4.11M 0.11%
39,460
-4,772
-11% -$497K
DRI icon
213
Darden Restaurants
DRI
$23.7B
$4.07M 0.11%
64,073
+5,929
+10% +$351K
EQNR icon
214
Equinor
EQNR
$108B
$4.04M 0.11%
225,600
+61,400
+37% +$1.19M
WES
215
DELISTED
Western Gas Partners Lp
WES
$4.03M 0.11%
63,550
+5,500
+9% +$373K
CNC icon
216
Centene
CNC
$33.4B
$4M 0.11%
99,594
-90,850
-48% -$3.26M
SRCL
217
DELISTED
Stericycle Inc
SRCL
$3.99M 0.11%
29,770
BCR
218
DELISTED
CR Bard Inc.
BCR
$3.96M 0.11%
23,170
-1,900
-8% -$325K
MNK
219
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$3.95M 0.11%
33,525
-40,925
-55% -$5.05M
NWL icon
220
Newell Brands
NWL
$2.4B
$3.91M 0.1%
95,100
-13,000
-12% -$521K
ETP
221
DELISTED
Energy Transfer Partners, L.P.
ETP
$3.87M 0.1%
101,740
-27,770
-21% -$1.13M
WFT
222
DELISTED
Weatherford International plc
WFT
$3.87M 0.1%
315,100
-491,700
-61% -$6.83M
EGN
223
DELISTED
Energen
EGN
$3.86M 0.1%
56,500
+29,600
+110% +$2.06M
VRTX icon
224
Vertex Pharmaceuticals
VRTX
$130B
$3.81M 0.1%
30,830
MGNI icon
225
Magnite
MGNI
$3.4B
$3.79M 0.1%
+253,055
New +$4.36M

Similar funds

Castleark Management's Q2 2015 Portfolio in Review

As of Q2 2015, Castleark Management held 421 positions worth $3.74B, down 9.7% from $4.15B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Castleark Management withdrew a net $540M in Q2 2015, closing 53 positions and reducing 163 holdings. Its most notable exit was Blackrock, an estimated $37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Castleark Management opened a new position in Morgan Stanley worth $36.2M.

  • Castleark Management's largest Q2 2015 buy was Morgan Stanley: 932,120 shares worth $36.2M.
  • Castleark Management added most to Amazon in Q2 2015, an estimated $26.4M increase.
  • Castleark Management's biggest Q2 2015 reduction was Medtronic, cutting an estimated $85.4M.
  • Castleark Management fully exited Blackrock in Q2 2015, selling an estimated $37M.
  • Castleark Management's ten largest holdings make up 18% of its $3.74B portfolio in Q2 2015.
  • Castleark Management opened 67 new positions and closed 53 in Q2 2015.
  • Castleark Management's portfolio value fell 9.7% quarter-over-quarter to $3.74B.

Based on Castleark Management's 13F filing for Q2 2015, filed 17 Aug 2015.